Fixed-dose combination tablets integrating integrase inhibitor, nucleoside reverse transcriptase inhibitors for simplified HIV therapy. Manufactured by multinational pharma companies, supplied via bulk procurement to NGOs, government health agencies, and hospital pharmacies for resource-limited settings.